A Study of UA026 Tablets in Healthy Adult Subjects and Adult Subjects With Moderate to Severe Plaque Psoriasis

PHASE1RecruitingINTERVENTIONAL

Enrollment

124

Participants

Timeline

Start Date

May 8, 2025

Primary Completion Date

March 1, 2026

Study Completion Date

June 1, 2026

Conditions

Plaque PsoriasisHealthy Volunteer

Interventions

DRUG

UA026

UA026 will be administered as tablet

DRUG

Placebo

Matching placebo will be administered as tablet

Trial Locations (1)

RECRUITING

Hangzhou First People's Hospital, Hangzhou

All Listed Sponsors

lead

Usynova Pharmaceuticals Ltd.

INDUSTRY